Trichuris Suis Ova (TSO) Suspension Versus Placebo in Active Crohn's Disease
Status:
Completed
Trial end date:
2014-02-01
Target enrollment:
Participant gender:
Summary
This study will run in centers in Germany, Denmark, Austria, Czech Republic, and Switzerland,
only.
This proof-of-concept study aims to evaluate the efficacy of three doses of oral TSO
suspension vs. placebo for the induction of remission in Crohn's disease.